![Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator - GOV.UK Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator - GOV.UK](https://assets.publishing.service.gov.uk/government/uploads/system/uploads/image_data/file/166637/s960_Gov_UK.jpg)
Second Pfizer/BioNTech bivalent COVID-19 booster vaccine approved by UK medicines regulator - GOV.UK
CDPH | Chicago Department of Public Health on X: "Hot off the press: If you are age 65+ or immunocompromised, talk to your healthcare provider about receiving a SECOND COVID-19 bivalent booster!
![Updated COVID-19 booster targets subvariants responsible for 98% of cases today | Malheur County Health Department Updated COVID-19 booster targets subvariants responsible for 98% of cases today | Malheur County Health Department](https://i0.wp.com/covidblog.oregon.gov/wp-content/uploads/2022/09/Bivalent_2.jpg?resize=526%2C526&ssl=1)
Updated COVID-19 booster targets subvariants responsible for 98% of cases today | Malheur County Health Department
![Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC) Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)](https://publichealthcollaborative.org/wp-content/uploads/2022/10/ENG_Twitter_updated-booster-doses-2.png)
Updated Toolkit: COVID-19 Booster Dose Messaging and Outreach Tools - Public Health Communications Collaborative (PHCC)
![Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm715152e1_BivalentVaccineEffectiveness_IMAGE_16Dec2022_1200x675.jpg?_=42783)
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 | MMWR
![Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19 Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_745226_16817225096615479.jpg)
Study highlights the importance of bivalent mRNA booster vaccination in populations at high risk of severe COVID-19
![Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ... Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e1_BivalentVECurrentSublineages_IMAGE_25Jan2023_1200x675-medium.jpg?_=95835)